Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dissecting Water, Sanitation, and Hygiene (WaSH) to Assess Risk Factors for Cholera in Shashemene, Oromia Region, Ethiopia.

Autor: Hailu D; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; School of Public Health, Hawassa University, Hawassa, Ethiopia., Jeon Y; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Gedefaw A; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia., Kim JH; Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea., Mraidi R; Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea., Getahun T; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Mogeni OD; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Mesfin Getachew E; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Jang GH; Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea., Mukasa D; Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea., Pak GD; Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea., Kim DR; Epidemiology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea., Ayele Abebe S; Statistics and Data Management Department, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Yeshitela B; Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Edosa M; Public Health Emergency Management, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Worku Demlie Y; Public Health Emergency Management, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Park SE; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; Department of Global Health and Disease Control, Yonsei University Graduate School of Public Health, Seoul, Republic of Korea., Teferi M; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 12; Vol. 79 (Supplement_1), pp. S53-S62.

Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia.

Autor: Park SE; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; Department of Global Health and Disease Control, Yonsei University Graduate School of Public Health, Seoul, Republic of Korea., Gedefaw A; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia., Hailu D; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia., Jeon Y; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Mogeni OD; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Jang GH; Biostatistics and Data Management (BDM) Department, International Vaccine Institute, Seoul, Republic of Korea., Mukasa D; Biostatistics and Data Management (BDM) Department, International Vaccine Institute, Seoul, Republic of Korea., Mraidi R; Biostatistics and Data Management (BDM) Department, International Vaccine Institute, Seoul, Republic of Korea., Kim DR; Biostatistics and Data Management (BDM) Department, International Vaccine Institute, Seoul, Republic of Korea., Getahun T; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Mesfin Getachew E; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Yeshitela B; Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Ayele Abebe S; Data Science Division, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Hussen M; Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Worku Demlie Y; Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Teferi M; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 12; Vol. 79 (Supplement_1), pp. S33-S42.

Retrospective Analysis of Cholera/Acute Watery Diarrhea Outbreaks in Ethiopia From 2001 To 2023: Incidence, Case Fatality Rate, and Seasonal and Multiyear Epidemic Patterns.

Autor: Worku Demlie Y; Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Gedefaw A; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia., Jeon Y; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Hailu D; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; School of Public Health, Hawassa University, Hawassa, Ethiopia., Getahun T; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Mogeni OD; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Mukasa D; Biostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea., Jang GH; Biostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea., Pak GD; Biostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea., Kim DR; Biostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea., Getachew EM; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Yeshitela B; Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Ayele Abebe S; Data Science Division, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Edosa M; Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Wossen M; Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Teferi M; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Park SE; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; Department of Global Health and Disease Control, Yonsei University Graduate School of Public Health, Seoul, Republic of Korea.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 12; Vol. 79 (Supplement_1), pp. S8-S19.